SCHEMBL22010396

SCHEMBL22010396

N/N=C(/SCC(=O)N1CCc2cc(C(N)=O)ccc21)N(N)c1ccc(C(=O)O)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 5/20 0.36
▸ RAB9A P51151 5/20 0.36
▸ MAPT P10636 5/20 0.36
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ POLB P06746 2/20 0.36
▸ RIPK1 Q13546 1/20 0.36
▸ ALDH1A1 P00352 7/20 0.36
▸ HPGD P15428 3/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ HDAC3 O15379 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ HDAC7 Q8WUI4 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC11 Q96DB2 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ HDAC9 Q9UKV0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010399 0.95 NPC1 (0.38) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL22009391 0.90 NOTUM (0.43) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL22016313 0.90 SLC22A12 (0.40) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL22009339 0.89 TP53 (0.44) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL22009392 0.87 TRIM24 (0.38) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL22009342 0.85 PIK3CD (0.38) MAPTSMN1; SMN2POLBALDH1A1KDM4E
SCHEMBL22009344 0.83 CYP11B2 (0.55) —
SCHEMBL22009336 0.82 POLB (0.34) MAPTSMN1; SMN2POLBALDH1A1HPGD
SCHEMBL22010009 0.76 PARP15 (0.38) NPC1RAB9AMAPTSMN1; SMN2POLB
SCHEMBL22010398 0.75 NOS1 (0.38) NPC1RAB9ASMN1; SMN2POLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3909577-A1 UBIQUITIN-LIGASE INHIBITORS FOR THE TREATMENT OF CANCER Fundación Profesor Novoa Santos (ES) 2021-11-17 — — EP disclosed
WO-2020099652-A1 COMPOUNDS THAT SELECTIVELY AND EFFECTIVELY INHIBIT HAKAI-MEDIATED UBIQUITINATION, AS ANTI-CANCER DRUGS FUNDACIÓN PROFESOR NOVOA SANTOS (ES) 2020-05-22 — — WO disclosed
EP-3653208-A1 COMPOUNDS THAT SELECTIVELY AND EFFECTIVELY INHIBIT HAKAI-MEDIATED UBIQUITINATION, AS ANTI-CANCER DRUGS Fundación Profesor Novoa Santos (ES) 2020-05-20 — — EP disclosed
Send feedback